Condition: Multiple Sclerosis · Sponsor: ModernaTX, Inc.
The primary objective of this trial is to evaluate the safety and reactogenicity of mRNA-1195 in participants with multiple sclerosis.
This description comes directly from the study's public registry record.
Moderna WeCare Team · 1-866-663-3762 · WeCareClinicalTrials@modernatx.com
Always discuss trial participation with your own doctor first.
| Boston Clinical Trials Inc - Internal Medicine | Boston, Massachusetts, United States | Terminated |
| Quest Research Institute | Farmington Hills, Michigan, United States | Recruiting |
| Sharlin Health & Neurology | Ozark, Missouri, United States | Terminated |
| Washington University School of Medicine Neurology Clinical Unit | St Louis, Missouri, United States | Recruiting |
| Oklahoma Medical Research Foundation (OMRF) MS Center of Excellence | Oklahoma City, Oklahoma, United States | Recruiting |
| University of Texas Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
| ANESC Research | El Paso, Texas, United States | Recruiting |
| Saturn Research Solutions | Plano, Texas, United States | Recruiting |
| University of the Sunshine Coast Clinical Trials | Birtinya, Queensland, Australia | Recruiting |
| North Bristol NHS Trust - Southmead Hospital | Bristol, United Kingdom | Recruiting |
| Cardiff and Vale University Health Board - University Hospital Wales | Cardiff, United Kingdom | Recruiting |
| Anne Rowling Regenerative Neurology Clinic, University of Edinburgh | Edinburgh, United Kingdom | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06735248